Archive: Articles
Page:
Startup Insider: Which Comes First, Dollars or Deal Flow?
By Early Investing on November 25, 2019
In Part 2 of our Startup Insider interview with Chris Lustrino, we chat about the growing equity crowdfunding space, startup funding strategies and more.
Mailbag: Commit or Go Home
By Early Investing on November 22, 2019
In this week’s Mailbag, the Early Investing team addresses pot stocks and startup investing commitments.
Know Your Risk Tolerance
By Adam Sharp on November 20, 2019
What one investor may find enticing another may find too risky. That’s why private investors need to understand their risk tolerance.
Quantum Computing Is (Almost) Here
By Andy Gordon on November 20, 2019
No industry is safe from disruption. Including computers. Quantum computing is the next big disruption... and it may be closer than you think.
Startup Investing Master Class: Understanding Crowdfunding Portals
By Early Investing on November 19, 2019
As a startup investor, you’ve got to peruse a lot of potential deals. But where can you find them? That’s where crowdfunding portals come in. These sites offer a platform for startups and investors to find each other. Portals allow investors to access startups’ offering circulars, goals, founder Q&As and…
Startup Insider: The Strategy of a Founder Plus the Knowledge of an Investor
By Early Investing on November 18, 2019
The First Stage Investor team sits down with Chris Lustrino, CEO and founder of KingsCrowd, to learn what his company has done so far, what it’s like to be on both the founder and investor side of things, and more.
Nothing Is Immune to Disruption – Including Breakfast
By Vin Narayanan on November 16, 2019
No industry is safe from disruption. Even milk and orange juice are in trouble.
The Fed Fesses Up
By Adam Sharp on November 15, 2019
The Federal Reserve is finally beginning to acknowledge the country’s massive debt problem. That’s an important step toward resolving it.
Cannabis Report: Why You Should Own These Five Cannabis Stocks
By Early Investing on November 14, 2019
In this special edition of the Cannabis Report, Adam Sharp joins us to explain why he’s so excited about the new First Stage Investor cannabis portfolio.
Two Ways to Resolve the Opioid Crisis
By Andy Gordon on November 13, 2019
More than 400,000 Americans have died from opioid overdoses. But there’s a solution - and two different methods to approach it.
On AngelList, Keep It Confidential
By Adam Sharp on November 12, 2019
AngelList has a strict privacy policy on its deals. Here’s why investors should take that very seriously.
The First Stage Investor Cannabis Portfolio Is Here
By Adam Sharp on November 12, 2019
The First Stage Investor cannabis portfolio is here! Here’s how you should view the cannabis market and which companies you need to invest in.
Startup Insider: How NowRx Is Creating the Ultimate Customer Service Experience
By Early Investing on November 11, 2019
In Part 3 of our Startup Insider interview with NowRx, we take a deep dive into the founders’ strategy.
Veterans Are Ready for Medical Marijuana
By Allison Brickell on November 11, 2019
A recent survey shows a huge number of veterans are interested in medical marijuana as a treatment option. Which means the current U.S. Department of Veterans Affairs marijuana policy needs a major update.
Mailbag: Understanding Startup Investing Rounds, Avoiding Uber and Lyft
By Early Investing on November 10, 2019
In this week’s Mailbag, the Early Investing team addresses startup funding rounds and whether Uber and Lyft are good buys.
News Fix: CBD Products Could Still Make You Fail a Drug Test
By Vin Narayanan on November 9, 2019
In the news this week: New York hemp farmers get a break, Saudi Arabia backs Travis Kalanick again and David Marcus says bitcoin isn’t a currency.